Format

Send to

Choose Destination
See comment in PubMed Commons below
Ann Neurol. 2008 Jul;64(1):88-92. doi: 10.1002/ana.21405.

Analysis of Lrrk2 R1628P as a risk factor for Parkinson's disease.

Author information

1
Department of Neuroscience, Mayo Clinic College of Medicine, Jacksonville, FL, USA.

Abstract

Common genetic variants that increase the risk for Parkinson's disease may differentiate patient subgroups and influence future individualized therapeutic strategies. Herein we show evidence for leucine-rich repeat kinase 2 (LRRK2) c.4883G>C (R1628P) as a risk factor in ethnic Chinese populations. A study of 1,986 individuals from 3 independent centers in Taiwan and Singapore demonstrates that Lrrk2 R1628P increases risk for Parkinson's disease (odds ratio, 1.84; 95% confidence interval, 1.20-2.83; p = 0.006). Haplotype analysis suggests an ancestral founder for carriers approximately 2,500 years ago. These findings support the importance of LRRK2 variants in sporadic Parkinson's disease. Ann Neurol 2008.

Comment in

PMID:
18412265
DOI:
10.1002/ana.21405
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Wiley
    Loading ...
    Support Center